Qun Kevin Fang

This inventor holds 37 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in CNS Disorders Treatment. Top assignees: Sepracor, Inc., Sunovion Pharmaceuticals Inc., Other. Active years: 1999-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qun Kevin Fang. Retrieved from https://idiyas.com/inventor/qun-kevin-fang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 37 (Patent Applications = 7)

% Patents Active = 64.9

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 377(Granted Patents)

Location History:

Wellesly, MA (US) (2004)
Wellesley, SC (US) (2008)
Wellesley, MA (US) (1999 - 2020)

Company Filing History:

Sunovion Pharmaceuticals Inc.

patents

1 out of 834,601

Other

patents

Years Active: 1999-2020

Loading Chart...

Areas of Expertise:

CNS Disorders

Heterocyclic Compounds

Histamine H3 Antagonists

Sibutramine Metabolites

Tramadol Analogs

Bupropion Metabolites

Erectile Dysfunction

Neuropathic Pain

Obesity Treatment

Attention Deficit Disorders

Asymmetric Grignard Synthesis

Zopiclone Derivatives

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10702486 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2020-07-07),

2. 10328036 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2019-06-25),

3. 9907764 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2018-03-06),

4. 9884844 - Heterocyclic compounds and methods of use thereof (2018-02-06),

5. 9498452 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2016-11-22),

6. 9072699 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine (2015-07-07),

7. 8658700 - [object Object] (2014-02-25),

8. 8497278 - Imidazo[1,2-a]pyridine compounds (2013-07-30),

9. 8404670 - Histamine H3 inverse agonists and antagonists and methods of use thereof (2013-03-26),

10. 8344030 - [object Object] (2013-01-01),

11. 8134029 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine (2012-03-13),

12. 8063032 - Histamine H3 inverse agonists and antagonists and methods of use thereof (2011-11-22),

13. 7902252 - Inhibitors of D-amino acid oxidase (2011-03-08),

14. 7790772 - [object Object] (2010-09-07),

15. 7589237 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine (2009-09-15),

Title: The Innovative Mind of Qun Kevin Fang

Introduction: Qun Kevin Fang, a talented inventor based in Wellesley, MA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Qun Kevin Fang holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Qun Kevin Fang has successfully brought several cutting-edge inventions to life, revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, Qun Kevin Fang has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: Qun Kevin Fang's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His impact on the technological landscape is sure to be felt for years to come.

Profile summary based on public USPTO records.